Mulligan T, Frick MF, Zuraw QC, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006; 60: 762-769.
Restore the man is organised and funded by Bayer and may contain some promotional content.
Licensed for: In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
This website is intended for Healthcare Professionals resident in the UK.
Page last modified 08/06/2020
PP-NEB-GB-0318 July 2020
Report Adverse Events Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: firstname.lastname@example.org.